Enterovirus A71 DNA-Launched Infectious Clone as a Robust Reverse Genetic Tool

• Published in: PloS one 2016-09, Vol.11 (9), p.e0162771-e0162771
• Main Authors: Tan, Chee Wah, Tee, Han Kang, Lee, Michelle Hui Pheng, Sam, I-Ching, Chan, Yoke Fun
• Format: Article
• Language: English
• Subjects: Animals; Biology and Life Sciences; Catalytic RNA; Cell Line, Tumor; Cercopithecus aethiops; Children; Cloning; Complications; Cytomegalovirus; Deoxyribonucleic acid; DNA; DNA polymerase; DNA, Viral - genetics; Encephalitis; Enterovirus; Enterovirus A, Human - genetics; Enterovirus A, Human - growth & development; Enterovirus A, Human - pathogenicity; Enterovirus A, Human - physiology; Enteroviruses; Fluorescence; Gene expression; Genes; Genetic aspects; Genetic engineering; Genetics; Genomes; Hand-foot-and-mouth disease; Heparan sulfate; Hepatitis; Herpesviridae; Humans; Infection; Infectious diseases; Kinases; Medicine; Neurological complications; Outbreaks; Plasmids; Promoter Regions, Genetic; Proteins; Research and Analysis Methods; Ribonucleic acid; RNA; Simian virus 40; Transcription (Genetics); Transcription termination; Transfection; Viral Plaque Assay; Virulence; Virus Replication; Viruses
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0162771

Enterovirus A71 (EV-A71) causes major outbreaks of hand, foot and mouth disease, and is occasionally associated with neurological complications and death in children. Reverse genetics is widely used in the field of virology for functional study of viral genes. For EV-A71, such tools are limited to clones that are transcriptionally controlled by T7/SP6 bacteriophage promoter. This is often time-consuming and expensive. Here, we describe the development of infectious plasmid DNA-based EV-A71 clones, for which EV-A71 genome expression is under transcriptional control by the CMV-intermediate early promoter and SV40 transcriptional-termination signal. Transfection of this EV-A71 infectious DNA produces good virus yield similar to in vitro-transcribed EV-A71 infectious RNA, 6.4 and 5.8 log10PFU/ml, respectively. Infectious plasmid with enhanced green fluorescence protein and Nano luciferase reporter genes also produced good virus titers, with 4.3 and 5.0 log10 PFU/ml, respectively. Another infectious plasmid with both CMV and T7 promoters was also developed for easy manipulation of in vitro transcription or direct plasmid transfection. Transfection with either dual-promoter infectious plasmid DNA or infectious RNA derived from this dual-promoter clone produced infectious viral particles. Incorporation of hepatitis delta virus ribozyme, which yields precise 3' ends of the DNA-launched EV-A71 genomic transcripts, increased infectious viral production. In contrast, the incorporation of hammerhead ribozyme in the DNA-launched EV-A71 resulted in lower virus yield, but improved the virus titers for T7 promoter-derived infectious RNA. This study describes rapid and robust reverse genetic tools for EV-A71.